AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
CryoSPHERE+ is a significant invention that is likely to improve patient care, boost results, and provide doctors with more comfort and confidence when performing treatments. Price Performance In the past six months, ATRC's shares have lost 34.2% against the industry's rise of 12.9%. The S&P 500 has gained 18.6% in the same time frame. Image Source: Zacks Investment Research More on the Launch The cryoSPHERE+ device, which is part of the cryoICE platform, is built upon the proven safety and efficacy of the cryoSPHERE device, which was cleared in November 2018 and has been used in more than 60,000 procedures to date. FDA 510(k) approval was granted to cryoSPHERE+ to temporarily suppress pain in adult patients by ablation of peripheral nerves and in adolescent patients (12-21 years) by ablation of intercostal nerves under direct observation. By concentrating energy at the ball tip, the cryoSPHERE+ gadget uses cutting-edge technology to reduce thermal loss and expedite the
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $57.00 to $49.00. They now have a "buy" rating on the stock.MarketBeat
- AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $42.00 to $34.00. They now have an "overweight" rating on the stock.MarketBeat
- AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $46.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
- Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]Yahoo! Finance
ATRC
Earnings
- 5/1/24 - Miss
ATRC
Sec Filings
- 5/2/24 - Form 10-Q
- 5/1/24 - Form 144
- 5/1/24 - Form 8-K
- ATRC's page on the SEC website